What Underlies the Benefit of Famotidine Formulations Used During COVID-19?
- PMID: 32777281
- PMCID: PMC7411504
- DOI: 10.1053/j.gastro.2020.07.051
What Underlies the Benefit of Famotidine Formulations Used During COVID-19?
Comment in
-
Reply.Gastroenterology. 2021 Apr;160(5):1900-1901. doi: 10.1053/j.gastro.2021.01.013. Epub 2021 Jan 13. Gastroenterology. 2021. PMID: 33453230 Free PMC article. No abstract available.
Comment on
-
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study.Gastroenterology. 2020 Sep;159(3):1129-1131.e3. doi: 10.1053/j.gastro.2020.05.053. Epub 2020 May 22. Gastroenterology. 2020. PMID: 32446698 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical